Assessing the new over-65 deduction and its implications for Social Security taxation, as well as new rules for charitable ...

Over the past three years, KBC Group has been the most profitable bank in our coverage in the eurozone. Only the Scandinavian banks have been more profitable in Europe as a whole. We believe that KBC ...

We believe Credit Agricole S.A. can earn a midcycle return on tangible equity of around 9%, slightly below of our 10% cost of equity assumption for Credit Agricole S.A. and below its 12% 2025 target.

Vanguard Primecap VPMCX continues to benefit from seasoned leadership, rock-bottom fees, and deep research. But even the best ...

The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the company is considering simplifying its portfolio amid a recent sales slump.

Malaysia has tightened rules around the movement of artificial-intelligence chips from the U.S., a hot-button issue for the Trump administration's trade policy. Investors are seeking details on how ...

--Facing criticism from the Trump administration over the project, Fed Chair Jerome Powell is asking the Fed's internal watchdog to review the costs of an extensive renovation of the central bank's ...

Wholesale sales rose 0.1% from the month before to a seasonally adjusted 84.20 billion Canadian dollars, the equivalent of about $61.5 billion, Statistics Canada said Monday. The figure was ...

BitMine Immersion Technologies said it has accumulated about $500 million worth of ether as part of its Ethereum treasury strategy. The company, which specializes in Bitcoin mining using immersion ...

Mike Wilson, Morgan Stanley's chief stock-market strategist, offers another reason why investors have thrown caution to the wind. Yes, there is the idea that the announced tariff rates won't actually ...

Corcept Therapeutics has filed for U.S. Food and Drug Administration approval of its relacorilant drug candidate for the treatment of patients with platinum-resistant ovarian cancer.

In the "higher for longer" interest-rate environment, with the Fed not cutting as quickly as some investors may have expected, Oppenheimer analyst Chris Kotowski expects "repricing of low-coupon ...